Cargando…
Aspirin and the metabolic hallmark of cancer: novel therapeutic opportunities for colorectal cancer
Aspirin is a well-known nonsteroidal anti-inflammatory drug (NSAID) that has a recognized role in cancer prevention as well as evidence to support its use as an adjuvant for cancer treatment. Importantly there has been an increasing number of studies contributing to the mechanistic understanding of...
Autores principales: | Hoskin, Ashley J., Holt, Amy K., Legge, Danny N., Collard, Tracey J., Williams, Ann C., Vincent, Emma E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Exploration Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501897/ https://www.ncbi.nlm.nih.gov/pubmed/37720350 http://dx.doi.org/10.37349/etat.2023.00155 |
Ejemplares similares
-
Aspirin reprogrammes colorectal cancer cell metabolism and sensitises to glutaminase inhibition
por: Holt, Amy K., et al.
Publicado: (2023) -
The role of B-Cell Lymphoma-3 (BCL-3) in enabling the hallmarks of cancer: implications for the treatment of colorectal carcinogenesis
por: Legge, Danny N, et al.
Publicado: (2020) -
Lysine Acetylation, Cancer Hallmarks and Emerging Onco-Therapeutic Opportunities
por: Hu, Meilan, et al.
Publicado: (2022) -
BCL-3 promotes a cancer stem cell phenotype by enhancing β-catenin signalling in colorectal tumour cells
por: Legge, Danny N., et al.
Publicado: (2019) -
Genetic and biological hallmarks of colorectal cancer
por: Li, Jiexi, et al.
Publicado: (2021)